Safety and Efficiency of γδ T Cell Against Breast Cancer(Her-, er-, and pr-)

Phase 1/2 Completed 40 enrolled Fuda Cancer Hospital, Guangzhou Jinan University Guangzhou · collab

RandomizedSingle-groupSingle-blindTreatment

Summary

In this study, effects of γδT cells on human breast cancer (her2-, er-,pr-) in combination with tumor reducing surgery, for example cryosurgery going to be investigated.

Timeline

Start: 2015-04
Primary completion: 2016-06
Completion: 2016-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	DC-CIK	Cell therapy	—	—
Subject	γδ T cell	Cell therapy	—	—

Safety and Efficiency of γδ T Cell Against Breast Cancer(Her-, er-, and pr-)

Summary

Timeline

Drugs

Indications